164 related articles for article (PubMed ID: 8867497)
21. Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors.
Strömberg E; Edebo A; Lundin BS; Bergin P; Brisslert M; Svennerholm AM; Lindholm C
Clin Exp Immunol; 2005 Apr; 140(1):117-25. PubMed ID: 15762883
[TBL] [Abstract][Full Text] [Related]
22. The immune response against Helicobacter pylori--a direct linkage to the development of gastroduodenal disease.
Ibraghimov A; Pappo J
Microbes Infect; 2000 Jul; 2(9):1073-7. PubMed ID: 10967287
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance.
Larussa T; Leone I; Suraci E; Imeneo M; Luzza F
J Immunol Res; 2015; 2015():981328. PubMed ID: 26525279
[TBL] [Abstract][Full Text] [Related]
24. Enhanced activation of cyclooxygenase-2 downregulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa.
Pellicanò A; Imeneo M; Leone I; Larussa T; Luzza F
Helicobacter; 2007 Jun; 12(3):193-9. PubMed ID: 17492998
[TBL] [Abstract][Full Text] [Related]
25. Increased interleukin-10 in Helicobacter pylori infection could be involved in the mechanism protecting from allergy.
Oderda G; Vivenza D; Rapa A; Boldorini R; Bonsignori I; Bona G
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):301-5. PubMed ID: 17873741
[TBL] [Abstract][Full Text] [Related]
26. HELICOBACTER PYLORI INFECTION AND IMMUNE PROFILE OF PATIENTS WITH DIFFERENT GASTRODUODENAL DISEASES.
Vinagre RMDF; Vinagre IDF; Vilar-E-Silva A; Fecury AA; Martins LC
Arq Gastroenterol; 2018; 55(2):122-127. PubMed ID: 30043859
[TBL] [Abstract][Full Text] [Related]
27. [Immune response Th1/Th2 to Helicobacter pylori and Helminths in co-infected patients].
Bravo LE; Matta AJ; Restrepo-Avenia JM
Rev Chil Pediatr; 2020 Jun; 91(3):363-370. PubMed ID: 32730516
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori inflammation, immunity, and vaccines.
D'Elios MM; Andersen LP
Helicobacter; 2007 Oct; 12 Suppl 1():15-9. PubMed ID: 17727455
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of gastric-vein lymphocytes with regard to the immune response to Helicobacter pylori.
Tricerri A; Guidi L; Frasca D; Costanzo M; Errani AR; Riccioni ME; Barattini P; Vangeli M; Bartoloni C; Coppola R; Doria G; Gasbarrini G
Scand J Gastroenterol; 1999 Aug; 34(8):757-64. PubMed ID: 10499475
[TBL] [Abstract][Full Text] [Related]
30. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
31. Impaired host immunity contributes to Helicobacter pylori eradication failure.
Borody T; Ren Z; Pang G; Clancy R
Am J Gastroenterol; 2002 Dec; 97(12):3032-7. PubMed ID: 12492186
[TBL] [Abstract][Full Text] [Related]
32. Effect of IL-4 on peripheral blood lymphocyte proliferation: implication in immunopathogenesis of H. pylori infection.
Fan XG; Yakoob J; Fan XJ; Keeling PW
Immunol Lett; 1995 Nov; 48(1):45-8. PubMed ID: 8847090
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.
Shi Y; Liu XF; Zhuang Y; Zhang JY; Liu T; Yin Z; Wu C; Mao XH; Jia KR; Wang FJ; Guo H; Flavell RA; Zhao Z; Liu KY; Xiao B; Guo Y; Zhang WJ; Zhou WY; Guo G; Zou QM
J Immunol; 2010 May; 184(9):5121-9. PubMed ID: 20351183
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa.
Pellicanò A; Sebkova L; Monteleone G; Guarnieri G; Imeneo M; Pallone F; Luzza F
Infect Immun; 2007 Apr; 75(4):1738-44. PubMed ID: 17220306
[TBL] [Abstract][Full Text] [Related]
35. Normal interleukin-12 production in individuals with antibodies to Helicobacter pylori.
Duchmann R; Scherer H; Neurath M; Knolle P; Meyer zum Büschenfelde KH
APMIS; 1997 Nov; 105(11):824-30. PubMed ID: 9393552
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori infection upregulates interleukin-18 production from gastric epithelial cells.
Shimada M; Ando T; Peek RM; Watanabe O; Ishiguro K; Maeda O; Ishikawa D; Hasegawa M; Ina K; Ohmiya N; Niwa Y; Goto H
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1144-50. PubMed ID: 18946358
[TBL] [Abstract][Full Text] [Related]
37. NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells.
Tran LS; Tran D; De Paoli A; D'Costa K; Creed SJ; Ng GZ; Le L; Sutton P; Silke J; Nachbur U; Ferrero RL
Cell Microbiol; 2018 May; 20(5):e12826. PubMed ID: 29392836
[TBL] [Abstract][Full Text] [Related]
38. T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection.
Jafarzadeh A; Larussa T; Nemati M; Jalapour S
Microb Pathog; 2018 Mar; 116():227-236. PubMed ID: 29407232
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production.
Larussa T; Leone I; Suraci E; Nazionale I; Procopio T; Conforti F; Abenavoli L; Hribal ML; Imeneo M; Luzza F
Helicobacter; 2015 Feb; 20(1):41-8. PubMed ID: 25308308
[TBL] [Abstract][Full Text] [Related]
40. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
